Gene · 1828
Papers3,287
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,287
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: Occupational bullous dermatosis: first report of skin lesions induced by PVC welding fume in a manufacturing worker. | Front Immunol | 2025 | 41080599 | PubTator, text mining | PubMed |
| Ectodermal dysplasias and isolated ectodermal anomalies: expanding the clinical and molecular spectrum in a cohort of 36 patients. | Eur J Pediatr | 2025 | 41062838 | PubTator, text mining | PubMed |
| From slit diaphragm to autoantigen formation: a SUMOylation-based perspective on minimal change disease. | Front Nephrol | 2025 | 41049872 | PubTator, text mining | PubMed |
| Stem Cell-Derived Exosomes: A Comprehensive Review of Biomedical Applications, Challenges, and Future Directions. | Int J Nanomedicine | 2025 | 40933023 | PubTator, text mining | PubMed |
| Netherton Syndrome: A Comprehensive Literature Review of Pathogenesis, Clinical Manifestations, and Therapeutic Strategies. | J Mother Child | 2025 | 40899446 | PubTator, text mining | PubMed |
| Bi-Allelic DSG1 Splice-Site Variant Identified in a Family With Non-Syndromic Striate Palmoplantar Keratoderma. | J Dermatol | 2025 | 40878888 | PubTator, text mining | PubMed |
| Tofacitinib as a Novel Therapeutic Option for Pemphigus Vulgaris: A Case Report and Mechanistic Insights. | Clin Cosmet Investig Dermatol | 2025 | 40860312 | PubTator, text mining | PubMed |
| Desmoglein-driven dynamic signaling in pemphigus vulgaris: a systematic review of pathogenic pathways. | NPJ Regen Med | 2025 | 40846710 | PubTator, text mining | PubMed |
| Antibodies to Laminin β4 in Pemphigoid Diseases: Clinical-Laboratory Experience of a Single Central European Reference Centre. | Antibodies (Basel) | 2025 | 40843678 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome system dysregulation in FAM111B-related poikiloderma and phenotypic spectrum expansion: new case reports and long-term follow-up. | EBioMedicine | 2025 | 40840166 | PubTator, text mining | PubMed |
| Pemphigus Foliaceus in a Patient With Pre-existing Atopic Dermatitis: A Case Report. | Cureus | 2025 | 40831828 | PubTator, text mining | PubMed |
| Longitudinal trends in immunological biomarkers, and predictors of relapse in pemphigus treated with rituximab: A prospective cohort study. | Indian J Dermatol Venereol Leprol | 2025 | 40826847 | PubTator, text mining | PubMed |
| Mitochondrial-dependent apoptosis and STAT3 activation induced by oxidative stress in pemphigus vulgaris. | Sci Rep | 2025 | 40813461 | PubTator, text mining | PubMed |
| Organoids/organs-on-chips towards biomimetic human artificial skin. | Burns Trauma | 2025 | 40740685 | PubTator, text mining | PubMed |
| Desmosomal cadherin tension loss in pemphigus vulgaris mediated by the inhibition of active RhoA at cell-cell adhesions. | iScience | 2025 | 40740498 | PubTator, text mining | PubMed |
| Dupilumab as Immunomodulatory Rescue for Severe Recalcitrant Pemphigus Vulgaris: A Case Report and Literature Review. | Clin Cosmet Investig Dermatol | 2025 | 40734984 | PubTator, text mining | PubMed |
| Mechanism Study on Inhibition of EPHA2 Expression Impaired Skin Barrier Function by Gefitinib. | Exp Dermatol | 2025 | 40734331 | PubTator, text mining | PubMed |
| Desmoglein 1 and 3 as potential markers of occult lymph node metastasis in oral cancer. | J Oral Maxillofac Pathol | 2025 | 40703823 | PubTator, text mining | PubMed |
| The effect of Hydrocortisone on implantation through upregulation of tight junction genes: A lab trial study. | JBRA Assist Reprod | 2025 | 40674556 | PubTator, text mining | PubMed |
| Editorial: Community series in autoantibodies, volume II. | Front Immunol | 2025 | 40672950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1828/papers?page=5